Vivos Therapeutics, Inc. (VVOS): Shareholders' Equity
-$1.49M
As of 2025-12-31
-$3.81M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.49M | n/m | 2026-04-15, Balance as of period end |
| 2024-12-31 | $7.95M | n/m | 2026-04-15, Balance as of period end |
| 2023-12-31 | $411.0K | -91.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $4.80M | -81.2% | 2024-07-30, Balance as of period end |
| 2021-12-31 | $25.54M | +51.0% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $16.92M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | -$2.94M | n/a | 2021-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$1.49M | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $10.20M | +18.8% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $66.43M | +10.0% |
| Biotricity Inc. (BTCY) | 2026-03-31 | -$34.68M | n/m |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $3.10M | -29.8% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$5.73M | n/m |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$77.19M | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $67.92M | -5.7% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $31.22M | -21.5% |
Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗